Literature DB >> 11418534

Faecal concentrations of piperacillin and tazobactam in elderly patients.

M H Wilcox, A Brown, J Freeman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11418534     DOI： 10.1093/jac/48.1.155

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  3 in total

1.  Tigecycline exhibits inhibitory activity against Clostridium difficile in the colon of mice and does not promote growth or toxin production.

Authors:  Robin L P Jump; Yuejin Li; Michael J Pultz; Georgios Kypriotakis; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2010-12-06       Impact factor: 5.191

2.  Acquisition of rectal colonization by vancomycin-resistant Enterococcus among intensive care unit patients treated with piperacillin-tazobactam versus those receiving cefepime-containing antibiotic regimens.

Authors:  David L Paterson; Carlene A Muto; Magdaline Ndirangu; Peter K Linden; Brian A Potoski; Blair Capitano; Robert A Bonomo; David C Aron; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2007-11-19       Impact factor: 5.191

3.  Do piperacillin/tazobactam and other antibiotics with inhibitory activity against Clostridium difficile reduce the risk for acquisition of C. difficile colonization?

Authors:  Sirisha Kundrapu; Venkata C K Sunkesula; Lucy A Jury; Jennifer L Cadnum; Michelle M Nerandzic; Jackson S Musuuza; Ajay K Sethi; Curtis J Donskey
Journal:  BMC Infect Dis       Date:  2016-04-18       Impact factor: 3.090
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.